Symposium Speakers

Calvin KuoCalvin Kuo, MD, PhD, Stanford University

Maureen Lyles D'Ambrogio Professor of Medicine
Professor, Chemical and Systems Biology
Lead, Cancer Biology Program, Stanford Cancer Center
Vice Chair, Basic and Translational Research, Department of Medicine, Stanford

Dr. Calvin Kuo MD, PhD is the Maureen Lyles D’Ambrogio Professor of Medicine (Hematology) at Stanford University School of Medicine.  He is Vice Chair for Basic Research in the Department of Medicine and Co-lead of the Cancer Biology Program at the Stanford Comprehensive Cancer Center. He received his A.B. from Harvard College, M.D. and Ph.D. degrees from Stanford University and completed Residency in Internal Medicine at Brigham and Women’s Hospital and Oncology subspecialty training at the Dana-Farber Cancer Institute. 

His research interests include modeling of cancer in 3D organoid cultures, biology of quiescent and proliferating intestinal stem cell populations, and molecular regulation of angiogenesis and the blood-brain barrier with relevance to stroke, cancer and diabetes. He is an elected member of the Association of American Physicians and the American Society for Clinical Investigation and has received awards including an NIH Transformative R01 and an American Heart Association Innovative Science Award. Dr. Kuo is a founder of Surrozen, Inc and Toma Biosciences, and serves on numerous foundation boards including the AP Giannini Foundation and the American Heart Association Silicon Valley Chapter.  

Ravi BellamkondaRavi Bellamkonda, PhD, Duke University

Vinik Dean of Engineering, Pratt School of Engineering
Professor, Biomedical Engineering, Pratt School of Engineering


Dr. Ravi Bellamkonda, PhD
is the Vinik Dean of the Pratt School of Engineering at Duke University. Prior to becoming dean, Bellamkonda served as the Wallace H. Coulter Professor and chair of the Department of Biomedical Engineering at Georgia Institute of Technology and Emory University. He is committed to fostering transformative research and pedagogical innovation as well as programs that create an entrepreneurial mindset amongst faculty and students.

A trained bioengineer and neuroscientist, Bellamkonda holds an undergraduate degree in biomedical engineering. His graduate training at Brown University was in biomaterials and medical science (with Patrick Aebischer), and his post-doctoral training at Massachusetts Institute of Technology focused on the molecular mechanisms of axon guidance and neural development (with Jerry Schneider and Sonal Jhaveri). His current research explores the interplay of biomaterials and the nervous system for neural interfaces, nerve repair and brain tumor therapy.

From 2014 to 2016, Bellamkonda served as president of the American Institute for Biological and Medical Engineering (AIMBE), the leading policy and advocacy organization for biomedical engineers with representation from industry, academia and government. Bellamkonda’s numerous awards include the Clemson Award for Applied Research from the Society for Biomaterials, EUREKA award from National Cancer Institute (National Institutes of Health), CAREER award from the National Science Foundation and Best Professor Award from the Georgia Tech Biomedical Engineering student body. 

Lawrence CarinLawrence Carin, PhD, Duke University 

Vice Provost for Research
Chair, Electrical and Computer Engineering, Pratt School of Engineering
Associate Professor, Electrical and Computer Engineering, Pratt School of Engineering

Dr. Lawrence Carin, PhD  earned the BS, MS, and PhD degrees in electrical engineering at the University of Maryland, College Park, in 1985, 1986, and 1989, respectively. In 1989 he joined the Electrical Engineering Department at Polytechnic University (Brooklyn) as an Assistant Professor, and became an Associate Professor there in 1994. In September 1995 he joined the Electrical Engineering Department at Duke University, where he is now a Professor, and Vice Provost for Research. From 2003-2014 he held the William H. Younger Distinguished Professorship, and he was ECE Department Chair from 2011-2014. Dr Carin's early research was in the area of electromagentics and sensing, and over the last 15 years his research has moved to applied statistics and machine learning. He has recently served on the Program Committee for the following machine learning conferences: International Conf. on Machine Learning (ICML), Neural and Information Processing Systems (NIPS), Artificial Intelligence and Statistics (AISTATS), and Uncertainty in Artificial Intelligence (UAI). He was previously an Associate Editor (AE) of the IEEE Trans. on Antennas and Propagation, the IEEE Trans. on Signal Processing, and the SIAM J. of Imaging Science. He is currently an AE for the J. of Machine Learning Research. He is an IEEE Fellow. 

Hans Clevers

Jenny Chang, MD, Houston Methodist Cancer Center

Emily Herrmann Chair in Cancer Research & Director, Cancer Center
Professor of Cancer, Institute for Academic Medicine

Dr. Jenny Chang, MD is the Director of Houston Methodist Cancer Center and Emily Herrmann Chair in Cancer Research in Houston, Texas. She obtained her medical degree at Cambridge University in England, and then completed fellowship training in medical oncology at the Royal Marsden Hospital/Institute for Cancer Research in the United Kingdom. She was also awarded a research doctorate from the University of London. Her recent work has focused on the intrinsic therapy resistance of cancer stem cells, which has led to several publications and international presentations. Dr. Chang’s clinical research aims to evaluate novel biologic agents in breast cancer patients.

Hans Clevers

Ashutosh Chilkoti, PhD, Alan L. Kaganov Professor, Biomedical Engineering, Duke University

Group Leader, Hubrecht Institute for Developmental Biology and Stem Cell Research
Professor, Molecular Genetics, University Medical Center Utrecht and Utrecht University
Director of Research, Princess Máxima Center for Pediatric Oncology

Dr. Hans Clevers, MD, PhD  was born and raised in the south of the Netherlands, and studied biochemistry and medicine in Utrecht. After an immunology PhD (1985), he trained as a molecular biologist through a 4-year Harvard postdoc. Back in Utrecht (1989), he became professor in immunology at the university hospital, director of the Hubrecht Institute for developmental biology (2002), and finally research director of the Princess Maxima Center for childhood cancer (2015). As president of the Royal Netherlands Academy (KNAW), he founded the Academy of Arts.

His work on the developmental signaling pathway Wnt led him to discoveries in the cancer and stem cell fields, ultimately resulting in technologies to grow human stem cells into mini-organs (organoids) in a dish. His work was awarded amongst others with the Louis Jeantet Prize and the Breakthrough Prize in Life Sciences. Dr. Clevers is a member of multiple learned societies including the KNAW, the National Academy of Sciences of the USA, the Academie Francaise, the Orden pour les Merites of Germany, and the Royal Society. He holds knighthoods in Holland, France, and Germany.

Hans Clevers

Hans Clevers, MD, PhD, UMC Utrecht and Utrecht University 

Group Leader, Hubrecht Institute for Developmental Biology and Stem Cell Research
Professor, Molecular Genetics, University Medical Center Utrecht and Utrecht University
Director of Research, Princess Máxima Center for Pediatric Oncology

Dr. Hans Clevers, MD, PhD  was born and raised in the south of the Netherlands, and studied biochemistry and medicine in Utrecht. After an immunology PhD (1985), he trained as a molecular biologist through a 4-year Harvard postdoc. Back in Utrecht (1989), he became professor in immunology at the university hospital, director of the Hubrecht Institute for developmental biology (2002), and finally research director of the Princess Maxima Center for childhood cancer (2015). As president of the Royal Netherlands Academy (KNAW), he founded the Academy of Arts.

His work on the developmental signaling pathway Wnt led him to discoveries in the cancer and stem cell fields, ultimately resulting in technologies to grow human stem cells into mini-organs (organoids) in a dish. His work was awarded amongst others with the Louis Jeantet Prize and the Breakthrough Prize in Life Sciences. Dr. Clevers is a member of multiple learned societies including the KNAW, the National Academy of Sciences of the USA, the Academie Francaise, the Orden pour les Merites of Germany, and the Royal Society. He holds knighthoods in Holland, France, and Germany.

Hans Clevers, MD, PhD University Medical Center Utrecht and Utrecht University, The Netherlands

Jonah Cool, PhD, Science Program Officer, Chan Zuckerberg Initiative

Yarui Diao, PhD, Assistant Professor of Cell Biology, Duke

Jessilyn Dunn, PhDAssistant Professor, Biomedical Engineering, Duke University

Michael Gao, Data Scientist, Duke Institute for Health Innovation

Charlie Gersbach, PhD, Director, Center for Advanced Genomic Technologies, Duke University

Geoffrey Ginsberg, MD, PhD, Director, Center for Applied Genomics & Precision Medicine, MEDx, Duke University

David Hsu, MD, PhD, Assistant Professor of Medicine, Duke

Ouwen Huang, Graduate Fellow, Duke

Calvin Kuo, MD, PhD

Vice Chair of Research, Lead of Cancer Biology Program
Stanford University

Kyle Lafata, PhD, Postdoctoral Fellow, Radiation Oncology, Duke

Steven Lipkin, MD, PhD, Vice Chair of Research, Director of Cancer Genetics Clinic, Weill Cornell Medicine

Michael Pencina, PhD, Vice Dean for Data Science and Information Technology, School of Medicine, Duke University

Ken Poss, PhD, Director of Regeneration Next Initiative, Duke University
Jatin Roper, MD,
 Assistant Professor of Medicine, Duke University
Luis Saraiva, PhD, Director, Metabolism and Diabetes Program, Sidra Medicine

Xiling Shen, PhD

Director, Woo Center for Big Data and Precision Health (DAP)
Duke University

Neil Surana, MD, PhD, Assistant Professor, Molecular Genetics and Microbiology, Duke University

Purushothama Tata, PhDAssistant Professor of Cell Biology, Duke University
 

Jessie Tenenbaum, PhD, Chief Data Officer, NC Department of Health and Human Services

 

 

 

Xiaofan Wang, PhD, Donald and Elizabeth Cooke Professor of Cancer Research, School of Medicine, Duke University

Zhaohui Wang, PhD, Executive Director, DAP 

·        

Vice Provost for Research